lek

The quick read

What's driving the attention

A popular cholesterol medication has been banned across Poland, prompting urgent warnings from health authorities and concern among patients.

The Polish Chief Pharmaceutical Inspectorate (GIF) has issued a full ban on a widely used cholesterol drug, affecting all production batches. This regulatory action has caused alarm among patients and healthcare providers. Concurrently, new scientific findings about a diabetes medication reveal unexpected effects, highlighting evolving pharmaceutical research.